PTEN and glioblastoma: We observed a significant difference in the median PFS (18.6 and 11.4 months, respectively; P = .003; Figure 1A) and OS (not reached and 15.7 months, respectively; P < .001; Figure 1B) in patients with and without PTEN loss and/or mutation in TERTp-wild-type GBM.